You are here

Docket Number 3513

Received: 
Wednesday, December 16, 2020
Commodity: 
Plant-Derived Recombinant Human Serum Albumins ("rHSA") and Products Containing Same
Investigation Number: 
337-TA-1238
Filed By: 
Beau Jackson
Firm/Organization: 
Husch Blackwell, LLP
Behalf Of: 
Ventria Bioscience Inc.
Confidential: 
Yes
Country: 
None
Description: 
Letter to Lisa R. Barton, Secretary, USITC; requesting that the Commission conduct an investigation under section 337 of the Tariff Act of 1930, as amended, regarding certain plant-derived recombinant human serum albumins (“rHSA”) and products containing same. The proposed respondents are Wuhan Healthgen Biotechnology Corp., China; ScienCell Research Laboratories, Inc., Carlsbad, CA; Aspira Scientific, Inc., Milpitas, CA; United States Biological Corporation, Salem, MA; eEnzyme LLC, Gaithersburg, MD; and antibodies-online, Inc., Germany.
Petition/Complaint Status: 
Instituted